Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protein Intake in Patients With Colorectal or Lung Cancer During First Line Treatment With Chemo (Radio) - or Immunotherapy When Receiving a Low Volume, Energy Dense and High Protein Oral Nutritional Supplement: a Randomized, Controlled Study

NCT05677958 is registered in ClinicalTrials.gov with Nutricia Research as lead sponsor.

NCT NCT05677958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05677958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protein Intake in Patients With Colorectal or Lung Cancer During First Line Treatment With Chemo (Radio) - or Immunotherapy When Receiving a Low Volume, Energy Dense and High Protein Oral Nutritional Supplement: a Randomized, Controlled Study
Lead sponsor
Nutricia Research
Phase
Not applicable
Overall status
Completed
Start date
January 17, 2019
Completion date
December 17, 2021
Enrollment
126 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, lung cancer